CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 8-K/A Event Exhibits
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change · Shareholder vote results · Other events
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
- SC TO-T/A Deal Tender Offer Statement
- 8-K Event Agreement ended · Other events
- SC 14D9/A Deal SC 14D9/A
- 8-K Event Material agreement
- SC 14D9/A Deal SC 14D9/A
Page 1 of 80 · 1,583 filings